自噬
AKT2型
骨质疏松症
癌症研究
成骨细胞
基因敲除
医学
内分泌学
调节器
化学
内科学
骨重建
细胞生物学
合成代谢
信号转导
作者
Qilian Ye,Ting Fu,Peixuan Li,Xuemei Long,Zhiyuan Zhang,Luwen Ye,Yanqiu Zhou,Shuanglin Peng,Qianke Tao,Jingang Xiao
出处
期刊:Bone
[Elsevier BV]
日期:2025-12-24
卷期号:204: 117770-117770
被引量:2
标识
DOI:10.1016/j.bone.2025.117770
摘要
Adipose-derived stem cells (ASCs) are crucial seed cells for bone defect repair. In diabetic osteoporosis (DOP), however, their osteogenic potential is impaired. This study found that ASCs from a pre-clinical DOP model, established in C57BL/6 J mice using a high-fat/high-sucrose diet combined with streptozotocin-induced insulin deficiency, exhibited suppressed osteogenic differentiation and impaired autophagy flux. This was accompanied by hyperactivation of the PI3K/AKT/mTOR signaling, particularly elevated AKT2 phosphorylation. Transcriptomic analysis confirmed enrichment of related pathways. Mechanistically, Akt2 overexpression suppressed osteogenesis and autophagy, while its knockdown restored both. Crucially, implanting sh Akt2 -treated DOP-ASCs into calvarial defects of DOP mice enhanced bone regeneration, improving bone volume, trabecular number, and collagen deposition. These findings identify Akt2 as a key regulator of ASC dysfunction in DOP and demonstrate that its targeted inhibition rescues osteogenic potential, offering a promising therapeutic strategy for diabetic osteoporotic bone repair. • Akt2 is hyperactivated in diabetic osteoporosis-derived adipose stem cells (ASCs). • Akt2 knockdown restores osteogenic differentiation and autophagy in diabetic ASCs. • Akt2 knockdown rescues bone regeneration in diabetic osteoporotic mice. • Targeting Akt2 represents a promising therapeutic strategy for diabetic bone repair.
科研通智能强力驱动
Strongly Powered by AbleSci AI